Wegovy vs Zepbound for Weight Loss: What the Evidence Shows

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where weight-loss questions get evidence-based answers instead of hype. Browse all Peptides & GLP-1 education

An independent editorial view: PlexusDx earns nothing from Novo Nordisk, Eli Lilly, or any brand discussed, and has no commercial relationship with them.

If your goal is weight loss specifically, the Wegovy-versus-Zepbound question is less about regulatory paperwork and more about lived experience: how much weight moves, how the ramp-up feels, what it costs to stay on, and why two people on the same drug can land in different places. This guide follows that decision from start to finish.

Framing the weight-loss decision

Both brands are FDA-approved for chronic weight management, so the choice is rarely about eligibility and more about fit. Wegovy is semaglutide (Novo Nordisk); Zepbound is tirzepatide (Eli Lilly). For orientation, liraglutide and dulaglutide are GLP-1-selective agents, and retatrutide is an investigational triple agonist not FDA-approved as of April 2026 — neither is the subject here, but they frame where these two sit in the class.

How each drives appetite and satiety

Weight loss on these agents flows from appetite and satiety changes. Semaglutide works through the GLP-1 receptor; tirzepatide adds GIP receptor activity as a dual agonist. Both slow gastric emptying and dampen post-meal glucose swings, which together reduce hunger and food intake. The dual-receptor design of tirzepatide is the structural reason it is dosed and studied on its own track rather than as a semaglutide equivalent.

Magnitude of weight change in the trials

The evidence lives in separate programs: STEP for semaglutide and SURMOUNT for tirzepatide, each measuring weight outcomes on its own terms. The most-cited direct comparison, SURPASS-2, tested tirzepatide against semaglutide 1 mg in type 2 diabetes and found greater mean weight reduction with tirzepatide in that trial. Because doses and endpoints differ across studies, the cleanest reading is trial by trial rather than a single winner.

The titration experience and side effects

Getting to a maintenance dose shapes the weight-loss journey more than most people expect. Both brands start low and step up slowly, and gastrointestinal symptoms — nausea, vomiting, diarrhea, constipation — cluster during that escalation. Both carry the class boxed warning for thyroid C-cell tumor risk from rodent studies and the same contraindications; rare serious events include pancreatitis, gallbladder disease, and dehydration-related kidney injury.

Access, price, and staying on therapy

Sustained weight loss depends on staying on therapy, and staying on therapy depends on access. As of April 2026, U.S. list prices across the FDA-approved brands run roughly $815 to $1,620 per month per manufacturer-published pricing. What you pay reflects insurance, the indication on the prescription, savings-card eligibility, and compounded-alternative availability through licensed pathways — variables that often decide whether someone can continue long enough to see results.

Why two people lose weight differently

Identical drug, different outcome is a familiar story, and genetics is part of the reason. FTO influences appetite and adiposity set-point; GLP1R encodes the receptor these drugs target; MC4R sits at the core of energy balance; and TCF7L2 ties into glucose handling and GLP-1 secretion. These pathway-level variants do not predict your weight loss on a given brand, but they help explain why response varies.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before a weight-loss protocol begins, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, GLP1R, MC4R, and TCF7L2 — so the plan starts with your biology, not a guess.

Related reading on PlexusDx: GoodRx Wegovy, Zepbound vs Wegovy Cost, Wegovy Prescription, and Wegovy Online.

Editorial note: this article is educational. PlexusDx offers only semaglutide and tirzepatide in the GLP-1 category and does not sell, prescribe, or recommend dulaglutide, liraglutide, retatrutide, cagrilintide, or related compounds. The Precision Peptide Genetic Test analyzes how genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified provider before starting a weight-loss protocol.

Start with your biology: take the Precision Peptide Genetic Test, or explore the Weight Management Protocols.

Frequently Asked Questions

Which leads to more weight loss, Wegovy or Zepbound?

Trial data is study-specific. SURPASS-2 reported greater mean weight reduction with tirzepatide than semaglutide 1 mg in type 2 diabetes, but weight-management trials used different doses and endpoints. Individual results vary widely, so the comparison is best discussed with a clinician rather than settled by a single figure.

How long before weight loss shows up?

Both brands escalate slowly over weeks to reach a maintenance dose, and early appetite changes often precede visible weight change. Because trials measured outcomes over months, expectations should be framed in that timeframe. A provider can help set realistic milestones based on your starting point and response.

Do the side effects interfere with weight-loss results?

Gastrointestinal symptoms are most common during dose escalation and usually ease as the body adjusts. Because tolerability affects whether someone stays on therapy, managing side effects during titration is part of protecting long-term results. Serious events are uncommon but warrant prompt medical attention.

Can genetics explain why my weight loss differs from someone else's?

Partly. Pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 shape baseline appetite and energy balance, which is one reason outcomes differ. The Precision Peptide Genetic Test maps this context but does not predict your specific weight loss on Wegovy or Zepbound.

Find more weight-loss explainers at the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.